Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

0.8968
+0.08149.98%
Post-market: 0.93000.0332+3.70%19:58 EDT
Volume:2.54M
Turnover:2.27M
Market Cap:165.42M
PE:-1.07
High:0.9500
Open:0.8998
Low:0.8421
Close:0.8154
Loading ...

Nektar Therapeutics Shares Rise After Upgrade From Oppenheimer

MT Newswires Live
·
17 hours ago

Nektar Therapeutics Raised to Outperform From Perform by Oppenheimer

Dow Jones
·
Yesterday

Nektar Therapeutics : Oppenheimer Raises to Outperform From Perform

THOMSON REUTERS
·
Yesterday

Nektar Therapeutics (NKTR) Q4 Earnings Miss Estimates (Revised)

Zacks
·
Yesterday

Oppenheimer Upgrades Nektar Therapeutics to Outperform From Market Perform, Price Target is $6

MT Newswires Live
·
Yesterday

Nektar Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
Yesterday

Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up

Zacks
·
Yesterday

Q4 2024 Nektar Therapeutics Earnings Call

Thomson Reuters StreetEvents
·
Yesterday

Nektar Therapeutics Price Target Maintained With a $6.50/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

William Blair Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)

TIPRANKS
·
13 Mar

Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

GuruFocus.com
·
13 Mar

Nektar Therapeutics expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

PR Newswire
·
06 Mar

Nektar Therapeutics expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
04 Mar

Nektar Therapeutics expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
28 Feb